Mental Health Blogs

Eli Lilly today announced that the FDA has approved its anti-depressant Cymbalta as a maintenance treatment for generalized anxiety disorder. That marks the sixth indication for the multi-billion selling drug, which is also approved for use in depression, anxiety, fibromyalgia and diabetic neuropathic pain.

Go to Source

Related posts:

1. Cymbalta Sales Way Up
2. Lilly Sponsors Fibromyalgia Website
3. Zyprexa Gets FDA Approval For Use In Adolescents
4. FDA Approves Seroquel As Add-On Treatment For Depression
5. Anti-Agitation Drug Submitted For FDA Approval